Sign In
Buy XOMA
$41.70
+0.0100 (+0.0240%)
At Close: Jun 03, 2026
EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Aug. 04, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V.
BOSTON and EMERYVILLE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (“HilleVax” or “the Company”) (NASDAQ: HLVX) and XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) an
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC and BOSTON and EMERYVILLE, Calif.
Collect Up To 11.5% From The Healthcare Sector
10:15am, Sunday, 06'th Jul 2025
Make your portfolio income-producing and provide valuable cash for your daily life. Aim to be healthy and have the money you need when emergencies arise. America is getting older. Healthcare income op
EMERYVILLE, Calif. and SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA) and Turnstone Biologics Corp. (“Turnstone” or the “Company”) (N
XOMA Royalty (XOMA) Moves 9.0% Higher: Will This Strength Last?
11:41am, Tuesday, 24'th Jun 2025
XOMA Royalty (XOMA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more streng
XOMA Royalty Declares Quarterly Preferred Stock Dividends
07:30am, Wednesday, 18'th Jun 2025
EMERYVILLE, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Roya
XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million
08:01am, Tuesday, 27'th May 2025
EMERYVILLE, Calif. and LUND, Sweden, May 27, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, and BioInvent International AB (“BioInvent”) (Nasdaq
XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates
09:50am, Tuesday, 13'th May 2025
XOMA Royalty (XOMA) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.26 per share. This compares to loss of $0.86 per share a year ago.
XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference
07:30am, Wednesday, 07'th May 2025
EMERYVILLE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen Hughes, and Chief Invest
XOMA Royalty Completes Sale of Kinnate Pipeline Assets
07:30am, Monday, 14'th Apr 2025
XOMA Royalty sold the remaining Kinnate pipeline assets for a total of up to $270 million in upfront and milestone payments, plus royalties on commercial sales at rates ranging from low single digits
BioInvent Receives Milestone Payment as Takeda moves mezagitamab into Phase 3
07:15am, Tuesday, 08'th Apr 2025
LUND, SWEDEN / ACCESS Newswire / April 8, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-clas
XOMA Royalty Corporation's Preferreds Still Offer Attractive Yields With A Biotech Twist
12:24am, Tuesday, 08'th Apr 2025
XOMA aggregates future biotech royalties and milestone rights for stable, diversified revenue streams. However, I believe its preferred shares (under tickers XOMAO and XOMAP) offer attractive yields w
XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference
07:30am, Wednesday, 02'nd Apr 2025
EMERYVILLE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA”; NASDAQ: XOMA), the biotech royalty aggregator, announced today Chief Investment Officer, Brad Sitko, will b
XOMA Royalty Declares Quarterly Preferred Stock Dividends
07:30am, Thursday, 20'th Mar 2025
EMERYVILLE, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Roy
